Follow The Filings

MBRX Moleculin Biotech

Moleculin Biotech earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by MBRX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MBRX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Jonathan P. Foster CFO
    Buy
    — 293,333 shares +2377% to stake
    Traded Aug 3 Filed Aug 5
    ↗
  2. Walter V Klemp CEO
    Buy
    — 533,333 shares +1720% to stake
    Traded Aug 3 Filed Aug 5
    ↗
  3. Donald H Picker Chief Science Officer
    Buy
    — 173,333 shares +23019% to stake
    Traded Aug 3 Filed Aug 5
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 option exercises and 10 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 3.03,5.03,8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 3.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13D — Filing Doc
DEF 14A FORM DEF 14A Filing Doc
DEFA14A FORM DEFA14A Filing Doc
424B5 FORM 424B5 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
424B5 FORM 424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
S-1/A FORM S-1/A Filing Doc
8-K 7.01,9.01 Filing Doc
S-1/A FORM S-1/A Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.